Brentuximab Plus AVD in Limited-stage Hodgkin Lymphoma
by on Tuesday, February 21st, 2012 | No Comments
Condition: Hodgkin Lymphoma
Interventions: Drug: Brentuximab Vedotin; Drug: Adriamycin, vinblastine, and dacarbazine
Sponsor: Massachusetts General Hospital
Not yet recruiting – verified February 2012
Read the original: Brentuximab Plus AVD in Limited-stage Hodgkin Lymphoma